“…The unwillingness to commence insulin therapy in this study was higher than that reported in the USA (28 and 33%) [20,21]. However, it is lower than those reported in different regions of Asia with the highest prevalence in Iran (77%), Malaysia (74.2%, 50.7%) and Singapore (70.6%) [9,23,24,31]. The differences in prevalence of unwillingness to begin insulin and the attitudes towards insulin therapy between countries may be related to cultural and health care system factors.…”